文献速递冠心病外科

桡动脉联合双侧乳内动脉搭桥的生存获益:荟萃分析

Survival effect of radial artery usage in addition to bilateral internal thoracic arterial grafting: A meta-analysis.
PubMed 文献 · J Thorac Cardiovasc Surg · 2021-07-24

该荟萃分析纳入6项倾向评分匹配的观察性研究,共2500例匹配患者,比较冠状动脉旁路移植术中双侧乳内动脉联合桡动脉(BITA+RA)与联合大隐静脉(BITA+SV)的长期结局。结果显示BITA+RA不增加早期死亡风险,且与更优的长期总体生存相关。

要点

  • BITA+RA不增加住院/30天死亡风险(OR 0.90,95%CI 0.36-2.28,P=.83)。
  • BITA+RA与长期生存获益显著相关(HR 0.71,95%CI 0.50-0.91,P=.031)。
  • 5年、10年、15年生存率BITA+RA均优于BITA+SV(log rank P=.02)。

核心结论

  • 在冠状动脉旁路移植术中,BITA+RA不增加手术风险,且与更优的长期总体生存相关。

研究设计与样本

  • 荟萃分析纳入6项倾向评分匹配的观察性研究,共2500例匹配患者(BITA+RA组1250例,BITA+SV组1250例)。
  • 主要终点为长期总体死亡率,次要终点为住院/30天死亡率;生存分析采用随机效应模型计算汇总风险比。

主要发现

  • BITA+RA与早期死亡率无统计学关联(OR 0.90,95%CI 0.36-2.28,P=.83)。
  • 平均随访时间7.5至12年,长期生存汇总分析显示两组差异显著, favoring BITA+RA(HR 0.71,95%CI 0.50-0.91,P=.031)。
  • BITA+RA与BITA+SV的5年生存率分别为96.2%与94.8%,10年为88.9%与87.4%,15年为83%与77.9%(log rank检验P=.02)。

关键数值与推荐

  • BITA+RA组与BITA+SV组早期死亡率比较:OR 0.90(95%CI 0.36-2.28,P=.83)。
  • 长期生存比较:HR 0.71(95%CI 0.50-0.91,P=.031), favoring BITA+RA。
  • 5年、10年、15年生存率BITA+RA vs BITA+SV分别为96.2% vs 94.8%、88.9% vs 87.4%、83% vs 77.9%(log rank P=.02)。

临床怎么用

  • 在冠状动脉旁路移植术中,可考虑将桡动脉作为第三动脉 graft 与双侧乳内动脉联合使用,以改善长期生存。
  • BITA+RA不增加早期死亡风险,可作为BITA+SV的合理替代策略。

局限性

  • 纳入研究均为观察性研究,即使经过倾向评分匹配仍可能存在残余混杂。
  • 样本量有限(共2500例匹配患者),随访时间7.5至12年不等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Little evidence shows whether the radial artery (RA) as third arterial graft provides superior outcomes compared with the use of the bilateral internal thoracic artery (BITA) and saphenous vein (SV) graft in patients undergoing coronary artery bypass grafting. A meta-analysis of propensity score-matched observational studies that compared the long-term outcomes of coronary artery bypass grafting with the use of BITA and the RA (BITA + RA) versus BITA and SV (BITA + SV) was performed. METHODS: Electronic databases from January 2000 to November 2020 were screened. Studies that reported long-term mortality were analyzed. The primary outcome was long-term overall mortality. A secondary end point was in-hospital/30-day mortality. Pooled hazard ratio with 95% confidence interval (CI) were calculated for survival and time-to-event analysis according to a random effect model. Differences were expressed as odds ratio with 95% CI for in-hospital/30-day mortality. RESULTS: Six propensity score-matched studies that reported on 2500 matched patients (BITA + RA: 1250; BITA + SV: 1250) were identified for comparison. The use of BITA + RA was not statistically associated with early mortality (odds ratio, 0.90; 95% CI, 0.36-2.28; P = .83). The mean follow-up time ranged from 7.5 to 12 years. The pooled analysis of long-term survival revealed a significant difference between the 2 groups favoring BITA + RA treatment (hazard ratio, 0.71; 95% CI, 0.50-0.91; P = .031). The survival rate for BITA + RA versus BITA + SV at 5, 10, and 15 years were: 96.2% versus 94.8%, 88.9% versus 87.4%, and 83% versus 77.9%, respectively (log rank test, P = .02). CONCLUSIONS: In patients with coronary artery bypass grafting, BITA + RA usage is not associated with higher rates of operative risk and is associated with superior long-term overall survival.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Formica F, Maestri F, D'Alessandro S, et al. Survival effect of radial artery usage in addition to bilateral internal thoracic arterial grafting: A meta-analysis. J Thorac Cardiovasc Surg. 2021. PMID: 34462132. doi:10.1016/j.jtcvs.2021.06.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。